W
Weimai Qingtong Medical Technology
AI-powered full-cycle digital healthcare management platform.
About Weimai Qingtong Medical Technology
Weimai Qingtong Medical Technology, operating as Weimai, is a digital healthcare solutions provider headquartered in Hangzhou, China. Founded in 2015 by Qiu Jialin, who serves as the company's CEO, Weimai has established itself as a significant online platform for full-cycle healthcare management in the country. The company's business model is centered around the concept of a "managed care organization" (MCO), which it has adapted for the Chinese market and refers to as C-MCO.
Weimai's core offering is an integrated healthcare management service that utilizes AI and digital tools to connect care across pre-hospital, in-hospital, and post-hospital settings. This platform is designed to address patient needs following diagnosis, testing, surgery, and hospitalization, encompassing services like medication management, follow-up consultations, and guidance on diet, exercise, and rehabilitation. By integrating online and offline care, the company aims to enhance the efficiency and quality of healthcare services while improving patient outcomes. Its proprietary CareAI technology is a key component in driving the adoption of its comprehensive care management solutions.
The company serves a large market, and as of the end of 2024, it had connected with over 2,500 public healthcare institutions and 200,000 licensed doctors across China, having served a cumulative total of one billion patients. Weimai has successfully raised significant funding to fuel its expansion and technological development. In January 2025, the company secured 200 million yuan (approximately $27.3 million) in a Series D funding round. This round saw participation from new investors, including CNCB Investment, Choice Capital, and Yuhang Transformation Industry Investment, as well as existing shareholders like Source Code Capital and Cenova Ventures. The capital is intended to further the development of its disease management solutions and AI-related research.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 21.7/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- Medical Devices
- Sector
- Skin Care, Health and Beauty, Core AI, Wellness and Beauty
- Technology
- Artificial Intelligence
- Business model
- Marketplace & ecommerce
- Client focus
- B2C
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Mar 2026 | $2.8M | $69M | SBI Group | ↗ |
| SERIES B✓Equity / VC | Feb 2025 | $2.8M | $69M | Wuxi Innovation Investment Group | ↗ |
Growth signals
Latest recorded traffic for Weimai Qingtong Medical Technology is 1.4K monthly website visits, down 26.3% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Weimai Qingtong Medical Technology in its local ecosystem
The Weimai Qingtong Medical Technology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
Yunnan Botanee Bio-Tech Group- XGXiamen Hengxing Group
CDH Investments- CGChuchang Investment Group
- BCBangqin Capital
Wuxi Innovation Investment Group
Series B and later1 investor entered at this stage
SBI Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Weimai Qingtong Medical Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Weimai Qingtong Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







